Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BOR15001L7 vs Docosanol for Recurrent Herpes Labialis
NCT03977792Phase 2Unknown
- Sponsor
- Laboratoire Boreaderme Inc.
- Start
- Sep 2020
- Primary completion
- Jul 2021
- Modality
- Transdermal Patches, Hydrogel Systems, Small Molecules
01
Overview
A Phase 2 trial of BOR15001L7 in herpes labialis, sponsored by Laboratoire Boreaderme Inc.. Status: unknown.
02
Drugs
BOR15001L7
03
Conditions
herpes labialis
Beyond the preview
Go deeper on NCT03977792.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03977792.